CD8A and non-small cell lung carcinoma: In vivo, PTE administration reduced tumor weight and volume in H358 xenograft models and significantly suppressed tumor growth in immunocompetent NSCLC models, correlating with increased intratumoral CD8+ T cell accumulation.